EFPIA - NEWSLETTER

EFPIA Newsletter 26 March 2020

EU will have to focus on long-term medical research ecosystem

After the coronavirus crisis is over, Europe will need policies that can create a research ecosystem in the long run as well as ensure access to medicines to the patients who need them in a way that is sustainable for health systems today and tomorrow, a top European pharmaceutical official told EURACTIV in an interview.

“We believe that by working together and sitting around the table, post-COVID, Europe can achieve both of these ambitions,” said Nathalie Moll, the director-general of the European Federation of Pharmaceutical Industries and Associations (EFPIA).

#WeWontRest in the fight against COVID-19

24 March 2020 Leadership at times of uncertainty

Dealing with the challenges of operating in a VUCA environment

26 March 2020 #COVID19 and cancer

An open letter from Bettina Ryll to all cancer patient advocates

25 March 2020 COVID-19 – Fighting the fakes

In times of crisis like the current COVID-19 pandemic, unfortunately, there is always someone looking to make a quick...

23 March 2020 Europe’s COVID-19 battle: Update on the supply of medicines to the patients that need them

At this point EFPIA members do not anticipate impacts to their supply chains unless disruption due to the COVID-19 outbreak...

Coronavirus – your questions answered

What we are reading

The global hunt for a coronavirus drug 26 March 2020 (Financial Times)

WHO expert: Finding and distributing COVID-19 vaccine in 18 months would be ‘historic’ 20 March 2020 (Euractiv)

ECCRT enters into an agreement with Qualitis for continuous online development of its staff... 25 March 2020 (ECCRT)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶